Tumor volumes in T3 supraglottic cancers treated with radiotherapy in the modern era: A study of the Canadian Head & Neck Collaborative Research Initiative
Head & Neck · 2024
DOI: 10.1002/hed.27608 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head & Neck, 2024. Verfasst von Nauman H Malik und 32 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Laryngeal Neoplasms. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
Purpose
To evaluate the association of primary tumor volume (TV) with overall survival (OS) and disease‐free survival (DFS) in T3 N0‐3M0 supraglottic cancers treated with intensity‐modulated radiotherapy (IMRT).
Methods
This was a retrospective cohort study involving 239 patients diagnosed with T3 N0‐3M0 supraglottic cancers between 2002 and 2018 from seven regional cancer centers in Canada. Clinical data were obtained from the patient records. Supraglottic TV was measured by neuroradiologists on diagnostic imaging. Kaplan–Meier method was used for survival probabilities, and a restricted cubic spline Cox proportional hazards regression analysis was used to analyze TV associations with OS and DFS.
Results
Mean (SD) of participants was 65.2 (9.4) years; 176 (73.6%) participants were male. 90 (38%) were N0, and 151 (64%) received concurrent systemic therapy. Mean TV (SD) was 11.37 (12.11) cm 3 . With mean follow up (SD) of 3.28 (2.60) years, 2‐year OS was 72.7% (95% CI 66.9%–78.9%) and DFS was 53.6% (47.4%–60.6%). Increasing TV was associated (per cm 3 increase) with worse OS (HR, 1.01, 95% CI 1.00–1.02, p < 0.01) and DFS (HR, 1.01, 95% CI 1.00–1.02, p = 0.02).
Conclusions
Increasing primary tumor volume is associated with worse OS and DFS in T3 supraglottic cancers treated with IMRT, with no clear threshold. The findings suggest that patients with larger tumors and poor baseline laryngeal function may benefit from upfront laryngectomy with adjuvant radiotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
- Department of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
- Department of Otolaryngology-Head and Neck Surgery, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
- Department of Neuroradiology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
- Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada.
- Department of Otolaryngology-Head and Neck Surgery, Princess Margaret Cancer Centre-University Health Network, University of Toronto, Toronto, Ontario, Canada.
ORCID-Profile: Nicolin Hainc, Christopher W Noel, Danielle MacNeil, Anthony C Nichols, Grégoire Morand, Joseph Dort, Steven Nakoneshny, Irene Karam
Zitieren
APA
Malik, N. H., Fu, R., Hainc, N., Noel, C. W., de Almeida, J. R., Hosni, A., Huang, S. H., Yu, E., Dzioba, A., Leung, A., Mangat, A., MacNeil, D., Nichols, A. C., Hiremath, S. B., Chakraborty, S., Jooya, A., Gaudet, M., Johnson-Obaseki, S., Whelan, J., …, & Eskander, A. (2024). Tumor volumes in T3 supraglottic cancers treated with radiotherapy in the modern era: A study of the Canadian Head & Neck Collaborative Research Initiative. Head & Neck. https://doi.org/10.1002/hed.27608
Vancouver
Malik NH, Fu R, Hainc N, Noel CW, de Almeida JR, Hosni A, et al. Tumor volumes in T3 supraglottic cancers treated with radiotherapy in the modern era: A study of the Canadian Head & Neck Collaborative Research Initiative. Head & Neck. 2024. doi:10.1002/hed.27608
BibTeX
@article{Malik2024,
author = {Malik, Nauman H and Fu, Rui and Hainc, Nicolin and Noel, Christopher W and de Almeida, John R and Hosni, Ali and Huang, Shao Hui and Yu, Eugene and Dzioba, Agnieszka and Leung, Andrew and Mangat, Arvindpaul and MacNeil, Danielle and Nichols, Anthony C and Hiremath, Shivaprakash B and Chakraborty, Santanu and Jooya, Alborz and Gaudet, Marc and Johnson-Obaseki, Stephanie and Whelan, Jonathan and Forghani, Reza and Hier, Michael P and Morand, Grégoire and Sultanem, Khalil and Dort, Joseph and Lysack, John and Matthews, Wayne and Nakoneshny, Steven and Gill, Gia and Globerman, Adam and Kerr, Paul and Maralani, Pejman and Karam, Irene and Eskander, Antoine},
title = {Tumor volumes in T3 supraglottic cancers treated with radiotherapy in the modern era: A study of the Canadian Head & Neck Collaborative Research Initiative},
journal = {Head & Neck},
year = {2024},
doi = {10.1002/hed.27608}
}
EUVIMED